{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:54:36Z","timestamp":1787964876936,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi University","doi-asserted-by":"publisher","award":["TSG-2022\\u20137934"],"award-info":[{"award-number":["TSG-2022\\u20137934"]}],"id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xphs.2025.103995","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:20:13Z","timestamp":1758086413000},"page":"103995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and characterization of ivermectin loaded microneedle formulations using 3D printed molds"],"prefix":"10.1016","volume":"114","author":[{"given":"Ozge","family":"Sariarslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-5495","authenticated-orcid":false,"given":"Emre","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-7105","authenticated-orcid":false,"given":"Sibel","family":"Ilbasmis-Tamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Tirnaksiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusun","family":"Acart\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103995_bib0001","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","article-title":"Ivermectin \u2013 Old drug, new tricks?","volume":"33","author":"Laing","year":"2017","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.xphs.2025.103995_bib0002","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.6308762","article-title":"Ivermectin: a potent new antiparasitic agent","volume":"221","author":"Campbell","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.xphs.2025.103995_bib0003","article-title":"Ivermectin: a multifaceted drug with a potential beyond anti-parasitic therapy","volume":"16","author":"Kaur","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2025.103995_bib0004","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2183\/pjab.87.13","article-title":"Ivermectin, 'wonder drug' from Japan: the human use perspective","volume":"87","author":"Crump","year":"2011","journal-title":"Proc Jpn Acad B Phys Biol Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00001813-199609000-00005","article-title":"The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor","volume":"7","author":"Didier","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.xphs.2025.103995_bib0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/DDDT.S237393","article-title":"Progress in understanding the molecular mechanisms underlying the antitumour effects of Ivermectin","volume":"14","author":"Liu","year":"2020","journal-title":"Drug Devel Ther"},{"key":"10.1016\/j.xphs.2025.103995_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25254","article-title":"Ivermectin as a potential therapeutic strategy for glioma","volume":"102","author":"Hu","year":"2024","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0008","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.2147\/DDDT.S308973","article-title":"Progress in redirecting antiparasitic drugs for cancer treatment","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Devel Ther"},{"key":"10.1016\/j.xphs.2025.103995_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0010","article-title":"Development and in vitro antiviral activity of ivermectin liposomes as a potential drug carrier system","volume":"357","author":"Kocas","year":"2024","journal-title":"Arch Pharm (Weinh)"},{"key":"10.1016\/j.xphs.2025.103995_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13555-020-00461-0","article-title":"Rosacea treatment: review and update","volume":"11","author":"Zhang","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.xphs.2025.103995_bib0012","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xphs.2025.103995_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CCID.S98091","article-title":"New developments in the treatment of rosacea - role of once-daily ivermectin cream","volume":"9","author":"Cardwell","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.xphs.2025.103995_bib0014","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13555-018-0249-y","article-title":"Topical ivermectin in the treatment of papulopustular rosacea: a systematic review of evidence and clinical guideline recommendations","volume":"8","author":"Ebbelaar","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.xphs.2025.103995_bib0015","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.xphs.2025.103995_bib0016","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xphs.2025.103995_bib0017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xphs.2025.103995_bib0018","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/jocd.16190","article-title":"Rosacea treatment with mussel adhesive protein delivered via microneedling: in vivo and clinical studies","volume":"23","author":"Luo","year":"2024","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.xphs.2025.103995_bib0019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5114\/ada.2024.142597","article-title":"A comparative study between fractional microneedling radiofrequency with systemic isotretinoin and fractional microneedling alone in the treatment of rosacea","volume":"41","author":"Hasan","year":"2024","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.xphs.2025.103995_bib0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1203475419867611","article-title":"The role of IL-17 in papulopustular rosacea and future directions","volume":"23","author":"Ali","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.xphs.2025.103995_bib0021","first-page":"369","article-title":"Microneedle-based vaccines","volume":"333","author":"Prausnitz","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.xphs.2025.103995_bib0022","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3762\/bjnano.12.77","article-title":"An overview of microneedle applications, materials, and fabrication methods","volume":"12","author":"Faraji Rad","year":"2021","journal-title":"Beilstein J Nanotechnol"},{"key":"10.1016\/j.xphs.2025.103995_bib0023","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1007\/s00216-018-1336-8","article-title":"Minimally invasive technique for measuring transdermal glucose with a fluorescent biosensor","volume":"410","author":"Brown","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.xphs.2025.103995_bib0024","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.103995_bib0025","first-page":"15","article-title":"Three dimensional printing and its applications focusing on microneedles for drug delivery","author":"Al-Nimry","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103995_bib0026","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijpharm.2018.01.031","article-title":"3D printing applications for transdermal drug delivery","volume":"544","author":"Economidou","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103995_bib0027","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17425247.2019.1660318","article-title":"Shaping the future: recent advances of 3D printing in drug delivery and healthcare","volume":"16","author":"Trenfield","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2025.103995_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106392","article-title":"The role of 3D printing technology in microengineering of microneedles","volume":"18","author":"Detamornrat","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.xphs.2025.103995_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122693","article-title":"A review of 3D-printing of microneedles","volume":"14","author":"Olowe","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103995_bib0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40005-024-00682-x","article-title":"Formulation and evaluation of ivermectin-loaded dissolving microarray patches for rosacea disease","volume":"54","author":"Anjani","year":"2024","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.xphs.2025.103995_bib0031","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/20415990.2024.2412511","article-title":"Modeling and evaluation of ivermectin release kinetics from 3D-printed tablets","volume":"15","author":"Briones Nieva","year":"2024","journal-title":"Ther Deliv"},{"key":"10.1016\/j.xphs.2025.103995_bib0032","article-title":"Development and optimization of hydrogel-forming microneedles fabricated with 3d-printed molds for enhanced dermal diclofenac sodium delivery: a comprehensive in vitro, ex vivo, and in vivo study","author":"Tuncel","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0033","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/02652048.2010.501397","article-title":"Maincent, ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables","volume":"27","author":"Camargo","year":"2010","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2025.103995_bib0034","first-page":"13","article-title":"Effect of temperature changes on critical micelle concentration for Tween Series surfactant","author":"Al-Koofee","year":"2013","journal-title":"Glob J Sci Front Res Chem"},{"key":"10.1016\/j.xphs.2025.103995_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13204-019-01190-3","article-title":"Fabrication of low-cost composite polymer-based micro needle patch for transdermal drug delivery","volume":"10","author":"Dathathri","year":"2020","journal-title":"Appl Nanosci"},{"key":"10.1016\/j.xphs.2025.103995_bib0036","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103995_bib0037","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijbiomac.2019.12.184","article-title":"Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules","volume":"146","author":"Vora","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2025.103995_bib0038","first-page":"745","article-title":"Nanoliposome enabled topical gel-based drug delivery system of ivermectin: fabrication, characterization, in vivo and in vitro investigation","volume":"2","author":"Kar","year":"2024","journal-title":"Intell Pharm"},{"key":"10.1016\/j.xphs.2025.103995_bib0039","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12249-024-02783-0","article-title":"Co-processed crystalline solids of Ivermectin with span((R)) 60 as solubility enhancers of ivermectin in natural oils","volume":"25","author":"de Vos","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2025.103995_bib0040","first-page":"372","article-title":"The characterization and dissolution performances of spray dried solid dispersion of ketoprofen in hydrophilic carriers","volume":"10","author":"Chan","year":"2015","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0041","first-page":"469","article-title":"Formation of orally fast dissolving fibers containing propolis by electrospinning technique","volume":"42","author":"Asawahame","year":"2015","journal-title":"Chiang Mai J Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0042","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/pharmaceutics14071432","article-title":"Manipulation of spray-drying conditions to develop an inhalable ivermectin dry powder","volume":"14","author":"Saha","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103995_bib0043","first-page":"5","article-title":"Simple and customizable method for fabrication of high-aspect ratio microneedle molds using low-cost 3D printing","author":"Krieger","year":"2019","journal-title":"Microsyst Nanoeng"},{"key":"10.1016\/j.xphs.2025.103995_bib0044","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.msec.2019.04.063","article-title":"3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery","volume":"102","author":"Economidou","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.xphs.2025.103995_bib0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jconrel.2020.10.021","article-title":"High resolution photopolymer for 3D printing of personalised microneedle for transdermal delivery of anti-wrinkle small peptide","volume":"329","author":"Lim","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.103995_bib0046","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jmbbm.2014.09.015","article-title":"Monitoring the penetration process of single microneedles with varying tip diameters","volume":"40","author":"R\u00f6mgens","year":"2014","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.xphs.2025.103995_bib0047","first-page":"26","article-title":"Measurement of epidermis, dermis, and total skin thicknesses from six different body regions with a new ethical histometric technique","author":"Oltulu","year":"2018","journal-title":"Turk J Plast Surg"},{"key":"10.1016\/j.xphs.2025.103995_bib0048","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/(SICI)1097-4628(19991128)74:9<2220::AID-APP11>3.0.CO;2-1","article-title":"Effect of polyvinylpyrrolidone molecular weights on morphology, oil\/water separation, mechanical and thermal properties of polyetherimide\/polyvinylpyrrolidone hollow fiber membranes","volume":"74","author":"Xu","year":"1999","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0049","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13346-015-0237-z","article-title":"Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation","volume":"5","author":"Lutton","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/jps.23439","article-title":"Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches","volume":"102","author":"Olatunji","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0051","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","article-title":"Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique","volume":"28","author":"Donnelly","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0052","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2005.02.002","article-title":"Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery","volume":"104","author":"Park","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.103995_bib0053","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40820-021-00611-9","article-title":"Engineering microneedle patches for improved penetration: analysis, skin models and factors affecting needle insertion","volume":"13","author":"Makvandi","year":"2021","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.xphs.2025.103995_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2021.104384","article-title":"Determination of the mechanical properties of polymeric microneedles by micromanipulation","volume":"117","author":"Du","year":"2021","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.xphs.2025.103995_bib0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41378-019-0088-8","article-title":"Simple and customizable method for fabrication of high-aspect ratio microneedle molds using low-cost 3D printing","volume":"5","author":"Krieger","year":"2019","journal-title":"Microsyst Nanoeng"},{"key":"10.1016\/j.xphs.2025.103995_bib0056","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.msec.2019.04.063","article-title":"3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery","volume":"102","author":"Economidou","year":"2019","journal-title":"Mater Sci Eng: C"},{"key":"10.1016\/j.xphs.2025.103995_bib0057","doi-asserted-by":"crossref","first-page":"184","DOI":"10.31351\/vol29iss1pp184-194","article-title":"Formulation and evaluation of Iornoxicam as dissolving microneedle patch","volume":"29","author":"Alkhiro","year":"2020","journal-title":"Iraqi J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0058","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41440-023-01466-w","article-title":"Gelatin-PVP dissolving microneedle-mediated therapy for controlled delivery of nifedipine for rapid antihypertension treatment","volume":"47","author":"Jana","year":"2024","journal-title":"Hypertens Res"},{"key":"10.1016\/j.xphs.2025.103995_bib0059","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1039\/C6RA27476E","article-title":"Fabrication of two-layer dissolving polyvinylpyrrolidone microneedles with different molecular weights for in vivo insulin transdermal delivery","volume":"7","author":"Lee","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2025.103995_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jmbbm.2014.09.015","article-title":"Monitoring the penetration process of single microneedles with varying tip diameters","volume":"40","author":"R\u00f6mgens","year":"2014","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.xphs.2025.103995_bib0061","article-title":"Drug delivery with dissolving microneedles: skin puncture, its influencing factors and improvement strategies","volume":"76","author":"Xiu","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2025.103995_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2021.104384","article-title":"Determination of the mechanical properties of polymeric microneedles by micromanipulation","volume":"117","author":"Du","year":"2021","journal-title":"J Mech Behav Biomed Mater"},{"key":"10.1016\/j.xphs.2025.103995_bib0063","first-page":"15","article-title":"Ex vivo transdermal delivery of nicotinamide mononucleotide using polyvinyl alcohol microneedles","author":"Sabbagh","year":"2023","journal-title":"Polym (Basel)"},{"key":"10.1016\/j.xphs.2025.103995_bib0064","first-page":"12","article-title":"Formulation and evaluation of niosomal alendronate sodium encapsulated in polymeric microneedles: in vitro studies, stability study and cytotoxicity study","author":"Zaid Alkilani","year":"2022","journal-title":"Nanomater (Basel)"},{"key":"10.1016\/j.xphs.2025.103995_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejps.2018.09.010","article-title":"Modelling the in-vitro dissolution and release of sumatriptan succinate from polyvinylpyrrolidone-based microneedles","volume":"125","author":"Ronnander","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103995_bib0066","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejpb.2008.09.013","article-title":"Characterisation of epidermal lipid composition and skin morphology of animal skin ex vivo","volume":"72","author":"Stahl","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.103995_bib0067","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40005-021-00536-w","article-title":"Quality by design approach to the development of transdermal patch systems and regulatory perspective","volume":"51","author":"Kim","year":"2021","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.xphs.2025.103995_bib0068","first-page":"1921","article-title":"Study on theory and application value of \"unification of medicines and excipients\" in Chinese materia medica preparations","volume":"48","author":"Zhang","year":"2017","journal-title":"Chin Tradit Herb Drugs"},{"key":"10.1016\/j.xphs.2025.103995_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122327","article-title":"Enhanced skin localization of metronidazole using solid lipid microparticles incorporated into polymeric hydrogels for potential improved of rosacea treatment: an ex vivo proof of concept investigation","volume":"628","author":"Sulistiawati","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103995_bib0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejpb.2014.03.019","article-title":"In vitro\/in vivo characterization of nanoemulsion formulation of metronidazole with improved skin targeting and anti-rosacea properties","volume":"88","author":"Yu","year":"2014","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:50:34Z","timestamp":1773136234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022354925004496"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103995","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of ivermectin loaded microneedle formulations using 3D printed molds","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103995"}}